References

• 1. Data on file, Study No. A163C-US-19-A40, 2019, Zoetis Inc.
• 2. Data on file, Study No. A163C-NL-19-A57, 2019, Zoetis Inc.
• 3. Data on file, Apoquel® chewable Market Research, 2021, Zoetis Inc.
• 4. Olivry, T. & Mueller, R. Critically appraised topic on adverse food reactions of companion animals (3): prevalence of cutaneous adverse food reactions in dogs and cats. BMC Vet Res. 2017;13:51.
• 5. Mueller RS, Olivry T, Prélaud P. Critically appraised topic on adverse food reactions of companion animals (2): common food allergen sources in dogs and cats. BMC Vet Res. 2016;12:9. doi:10.1186/s12917-016-0633-8.
• 6. Aleo MM, Galvan EA, Fleck TJ, et al. Effects of oclacitinib and prednisolone on skin test sensitivity [abstract]. Vet Dermatol. 2013;24(3):297.
• 7. Fleck T, Michels G, Gonzales AG, King V. Evaluation of the Onset of a Single Oral Dose of Oclacitinib Chewable Tablets at 0.4 mg/kg in a Canine Model of IL-31 Induced Pruritus. Zoetis Study A162R-US-20-B05. 15 July 2020.
• 8. Cosgrove SB, Wren JA, Cleaver DM, et al. Efficacy and safety of oclacitinib for the control of pruritus and associated skin lesions in dogs with canine allergic dermatitis. Vet Dermatol. 2013;24(5):479-e114. doi:10.1111/vde.12047.
• 9. Cosgrove SB, Wren JA, Cleaver DM, et al. A blinded, randomized, placebo-controlled trial of the efficacy and safety of the Janus kinase inhibitor oclacitinib (Apoquel®) in client-owned dogs with atopic dermatitis. Vet Dermatol. 2013;24(6):587-e142. doi:10.1111/vde.12088.
• 10. Gonzales AJ, Bowman JW, Fici GJ, et al. Oclacitinib (Apoquel®) is a novel Janus kinase inhibitor with activity against cytokines involved in allergy. J Vet Pharmacol Ther. 2014;37(4):317-324. doi:10.1111/jvp.12101.
• 11. Coutinho AE, Chapman KE. The anti-inflammatory and immunosuppressive effects of glucocorticoids, recent developments and mechanistic insights. Mol Cell Endocrinol. 2011;335(1):2-13. doi:10.1016/j.mce.2010.04.005.
• 12. Guaguère E, Steffan J, Olivry T. Cyclosporin A: a new drug in the field of canine dermatology. Vet Dermatol. 2004;15(2): 61-74. doi:10.1111/j.1365-3164.2004.00376.x.
• 13. Data on file, Study Report No. C863R-US-12-018, Zoetis Inc 07 Jun 2023 (v0.3).